跳至主要内容
临床试验/ACTRN12615001340527
ACTRN12615001340527已完成未知

A First In Human Radiofrequency (RF) Balloon Catheter Ablation to Isolate Pulmonary Veins in the Treatment of Patients with Paroxysmal Atrial Fibrillation

Boston Scientific0 个研究点目标入组 127 人开始时间: 2015年12月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
127

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • History of symptomatic paroxysmal and atrial fibrillation within the past year documented by ECG
  • Suitable candidate for catheter non-emergent intra-cardiac mapping and ablation

排除标准

  • Structural heart disease of clinical significance including previous cardiac surgery (excluding CABG or mitral valve repair)
  • Documented EF <30%
  • Left atrial diameter of >55mm
  • Contraindication to anticoagulation therapy
  • Unstable angina or ongoing myocardial ischemia
  • Myocardial infarction within 3 months of enrollment
  • Congenital heart disease where the underlying abnormality increases the risk of the ablation
  • Prior Atrial Septal Defect or Patent Foramen Ovale Closure with a device using a transcatheter percutaneous approach
  • Hypertrophic cardiomyopathy (LV septal wall thickness >1.5cm)
  • Pulmonary hypertension (>50mm Hg)
  • Prior ablation for atrial fibrillation
  • Enrollment in any other ongoing arrhythmia study protocol
  • Patients with severely impaired kidney function as measured by Cockcroft-Gault Glomerular Filtration Rate (GFR) 3 with a GFR < 29
  • Active gastrointestinal bleeding, infection or fever (>100.5/38C) or sepsis
  • Short life expectancy (<1 year) due to illness such as cancer, pulmonary,hepatic or renal disease
  • Significant anemia (hemoglobin < 8.0 / dl)
  • Severe uncontrolled systemic hypertension with systolic >200mm Hg within ast 30 days
  • Documented anaphylaxis during previous exposure to contrast media
  • Bleeding or clotting disorders or thrombotic disorder under treatment
  • Uncontrolled diabetes
  • Women who are pregnant and not willing to use contraception for the duration of the study
  • Severe COPD (identified by an FEV1 <1)
  • Unwilling or unable to comply with any protocol or follow up requirements

研究者

相似试验